Journal
NATURE REVIEWS RHEUMATOLOGY
Volume 7, Issue 12, Pages 685-686Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrrheum.2011.154
Keywords
-
Categories
Ask authors/readers for more resources
The use of biologic therapies for off-label conditions in daily clinical practice is increasing, yet few studies have detailed the safety of these agents with regards to infection in patients with systemic autoimmune disease. New research offers a glimpse at the infection rates in these vulnerable patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available